Biology subjects

Fontanesi, F.

Publications and source records attributed to Fontanesi, F..

6 recordsLinked to original sources

bioRxiv2026

The mitoribosome-associated factor Mrx9 acts as a negative regulator of the prohibitin/m-AAA complex

The synthesis of mitochondrial-encoded polypeptides is an essential process, primarily regulated at the posttranscriptional level. In yeast, many regulatory factors have been described as acting in proximity to the mitoribosome to promote efficient translation; however, the precise mechanisms by which these components function remain largely unknown. Here, we expand on findings concerning a previously studied mitoribosome interactor, Mrx9, which is found in large expressosome-like assemblies of mitoribosome clusters. Mrx9 was initially linked to mitochondrial translation and was suggested to be associated with the splicing of COX1 and COB transcripts. Our current data show that Mrx9 is associated with the PHB/m-AAA complex at the polypeptide exit tunnel of the mitoribosome. Overexpression of Mrx9 impairs the proteolytic functions of Yta10 and Yta12 within the prohibitin complex, leading to splicing defects; accumulation of aberrant polypeptides; and a noticeable impairment in the processing of the essential mitoribosomal protein bL32m. These findings support a regulatory role for Mrx9 in the PHB/m-AAA complex by modulating the activities of both Yta10 and Yta12.

molecular biology↗

bioRxiv2026

Matrix nucleotide homeostasis couples energetic state to mitochondrial translation

Mitochondrial protein synthesis is essential for oxidative phosphorylation, yet how organellar energetic state regulates the mitochondrial translation machinery remains poorly understood. Here, we show that mitochondrial translation is acutely sensitive to ATP synthase-dependent bioenergetic state. Pharmacological inhibition of the F1Fo-ATP synthase with oligomycin or citreoviridin rapidly and selectively suppresses mitochondrial protein synthesis, while mitoribosome profiling reveals a genome-wide loss of productive ribosome engagement. ATP synthase inhibition induces inner-membrane hyperpolarization, depletes bioavailable matrix ATP, and reduces matrix GTP availability. Relieving hyperpolarization restores nucleotide pools and mitochondrial translation despite persistent ATP synthase inhibition, whereas selective restoration of matrix GTP markedly rescues protein synthesis when adenine nucleotide exchange is restricted. These findings identify matrix GTP availability as a proximal energetic constraint on mitochondrial translation and reveal an organelle-intrinsic mechanism coupling ATP synthase-dependent bioenergetic state to mitoribosome activity.

cell biology↗

bioRxiv2024

Bioengineered yeast tethered respiratory supercomplexes reveal mechanisms governing efficient substrate utilization

The mitochondrial respiratory chain (MRC) enzymatic complexes, essential for aerobic energy transduction in eukaryotic cells, are organized into evolutionarily conserved higher-order structures known as supercomplexes (SCs). The elucidation of the physiological relevance of respiratory SCs is essential for our understanding of mitochondrial function and cellular bioenergetics, yet it has been severely hampered by the limited availability of experimental models isolating SC formation as the sole variable. In the yeast Saccharomyces cerevisiae, where SCs are formed by the association of complexes III and IV into III2IV1 and III2IV2 configurations, compelling evidence suggests that SCs confer a competitive advantage by facilitating cytochrome c diffusion along the SC surface and enhancing respiratory rates. However, the significance of the proposed MRC plasticity and the role of distinct SC conformations in substrate utilization remain unresolved, leaving critical gaps in our understanding of mitochondrial bioenergetics and the adaptive evolution of energy transduction. To address these open questions, we engineered a yeast strain expressing a covalently linked III2IV2 SC, whose high-resolution structure is virtually identical to wild-type. Exclusive expression of this tethered SC supports robust overall respiratory activity but selectively affects mitochondrial respiration of cytosolically-generated NADH. This is attributable to the preferential interaction of distinct SC species with mitochondrial NADH dehydrogenases. We propose that in yeast mitochondria, substrate-driven formation of defined respirasome-like SC organizations contributes to the optimization of electron fluxes across the MRC and support metabolic plasticity.

biochemistry↗

bioRxiv2024

Arginyltransferase1 drives a mitochondria-dependent program to induce cell death

Cell death regulation is essential for stress adaptation and/or signal response. Past studies have shown that eukaryotic cell death is mediated by an evolutionarily conserved enzyme, arginyltransferase1 (Ate1). The downregulation of Ate1, as seen in many types of cancer, prominently increases cellular tolerance to a variety of stressing conditions. Conversely, in yeast and mammalian cells, Ate1 is elevated under acute oxidative stress conditions and this change appears to be essential for triggering cell death. However, studies of Ate1 were conventionally focused on its function in inducing protein degradation via the N-end rule pathway in the cytosol, leading to an incomplete understanding of the role of Ate1 in cell death. Our recent investigation shows that Ate1 dually exists in the cytosol and mitochondria, the latter of which has an established role in cell death initiation. Here, by using budding yeast as a model organism, we found that mitochondrial translocation of Ate1 is promoted by the presence of oxidative stressors and is essential for inducing cell death with characteristics of apoptosis. Also, we found that Ate1-induced cell death is dependent on the formation of the mitochondrial permeability pore and at least partly dependent on the action of mitochondria-contained factors including the apoptosis-inducing factor, but is not directly dependent on mitochondrial electron transport chain activity or its derived reactive oxygen species (ROS). Furthermore, our evidence suggests that, contrary to widespread assumptions, the cytosolic protein degradation pathways including ubiquitin-proteasome, autophagy, or endoplasmic reticulum (ER) stress response has little or negligible impacts on Ate1-induced cell death. We conclude that Ate1 controls the mitochondria-dependent cell death pathway.

biochemistry↗

bioRxiv2023

The human mitochondrial mRNA structurome reveals mechanisms of gene expression

The mammalian mitochondrial genome encodes thirteen oxidative phosphorylation system proteins, crucial in aerobic energy transduction. These proteins are translated from 9 monocistronic and 2 bicistronic transcripts, whose native structures remain unexplored, leaving fundamental molecular determinants of mitochondrial gene expression unknown. To address this gap, we developed a mitoDMS-MaPseq approach and used DREEM clustering to resolve the native human mitochondrial mt-mRNA structurome. We gained insights into mt-mRNA biology and translation regulatory mechanisms, including a unique programmed ribosomal frameshifting for the ATP8/ATP6 transcript. Furthermore, absence of the mt-mRNA maintenance factor LRPPRC led to a mitochondrial transcriptome structured differently, with specific mRNA regions exhibiting increased or decreased structuredness. This highlights the role of LRPPRC in maintaining mRNA folding to promote mt-mRNA stabilization and efficient translation. In conclusion, our mt-mRNA folding maps reveal novel mitochondrial gene expression mechanisms, serving as a detailed reference and tool for studying them in different physiological and pathological contexts.

molecular biology↗

bioRxiv2022

Empagliflozin reduces renal lipotoxicity in experimental Alport syndrome

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are anti-hyperglycemic agents that prevent glucose reabsorption in proximal tubular cells. SGLT2i improves renal outcomes in both diabetic and non-diabetic patients, indicating it may have beneficial effects beyond glycemic control. Here, we demonstrate that SGLT2i affects energy metabolism and renal lipotoxicity in experimental Alport syndrome (AS). In vitro, we found that SGLT2 protein expression levels in human and mouse podocytes were similar to tubular cells. Newly established immortalized podocytes from Col4a3 knockout mice (AS podocytes) accumulate lipid droplets along with increased apoptosis when compared to wildtype podocytes. Treatment with SGLT2i empagliflozin reduces lipid droplet accumulation and apoptosis in AS podocytes. Empagliflozin inhibits the utilization of glucose/pyruvate as a metabolic substrate in AS podocytes. In vivo, we demonstrate that empagliflozin reduces albuminuria and prolongs the survival of AS mice. Empagliflozin-treated AS mice show decreased serum blood urea nitrogen and creatinine levels in association with reduced triglyceride and cholesterol ester content in kidney cortices when compared to AS mice. Lipid accumulation in kidney cortices correlates with the decline in renal function. In summary, empagliflozin reduces renal lipotoxicity and improves kidney function in experimental AS in association with the energy substrates switch from glucose to fatty acids in podocytes.

cell biology↗